MedPath

BUVIDAL 160 mg SOLUCION INYECTABLE DE LIBERACION PROLONGADA

BUVIDAL 160 mg SOLUCION INYECTABLE DE LIBERACION PROLONGADA

Pending
Register Number

1181336009

Prescription Type

Uso Hospitalario

Authorization Date

Jun 23, 2021

Dosage Form

SOLUCION INYECTABLE DE LIBERACION PROLONGADA

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1181336009
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

BUPRENORFINAActive
Quantity: 160 mg
Name: BUPRENORFINA

ATC CLASSIFICATION (3)

N07B
N07BC
N07BC01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.